Mast Therapeutics SVRA 深 沪
等待开盘 08-28 09:30:00 美东时间
3.29
-0.020
-0.60%
华盛通- 最 高3.38
- 今 开3.31
- 成交量 108.86万股
- 最 低 3.23
- 昨 收 3.31
- 总市值 5.69亿
- 52周最高 4.70
- 市盈率 静 --
- 换手率 0.63%
- 52周最低 1.89
- 委 比 -43.79%
- 总股本 1.73亿
- 历史最高 17.187
- 量 比 0.51
- 振 幅 4.53%
- 历史最低 0.69
- 每 手 1
- 风险率 0.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Savara upgraded at H.C. Wainwright on potential refiling of marketing application
H.C. Wainwright upgraded Savara (NASDAQ:SVRA) to Buy from Neutral and raised its price target to $5 from $2 per share on Friday, citing a potential resubmission of the company’s marketing application ...
08-16 03:09
HC Wainwright & Co. Upgrades Savara to Buy, Raises Price Target to $5
HC Wainwright & Co. analyst Andrew S. Fein upgrades Savara (NASDAQ:SVRA) from Neutral to Buy and raises the price target from $2 to $5.
08-15 21:09
Savara Re-elects Board Members at Annual Meeting
Savara ( ($SVRA) ) has provided an announcement. On June 5, 2025, Savara Inc. h...
06-07 05:23
美股大行评级 | 英伟达、赛富时、C3.ai、Veeva Systems等获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Cogent Biosciences(COGT)"超配"评级，目标价从21美元升至25美元</p> <p>• Chardan Capital：维持Taysha Gene Therapies(TSHA)"买入"
05-30 09:09
美股大行评级 | 拼多多遭多家大行下调评级！Redburn Atlantic首予博通"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1134767544930545665.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持AnaptysBio(ANAB)"买入"评级，目标价从54美元升至90美元</p> <p>• Canaccord Genuity：维持Bridger Aerospace Gr(BAER)"买入"评
05-29 09:53
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers SCWorx (NASDAQ:WORX) shares rose 60.0% to $0.64 during Tuesday's regul...
05-28 01:05
Savara shares are trading lower after the company announced it received a refusal to file letter from the FDA for its biologics license application.
Savara shares are trading lower after the company announced it received a refus...
05-27 20:30
Savara Faces FDA Setback for MOLBREEVI Application
Savara ( ($SVRA) ) has issued an announcement. On May 27, 2025, Savara Inc. ann...
05-27 20:27
Hercules Capital declares $0.47 dividend
Hercules Capital (NYSE:HTGC) declares $0.40/share base quarterly and 0.07 supplemental dividend, in line with previous. Forward yield 10.47% Payable May 20; for shareholders of record May 13; ex-div ...
04-30 01:10
